10 Sylvan Way
Parsippany, NJ 07054
United States
973 822 7000
https://www.zoetis.com
Secteur(s): Healthcare
Secteur d’activité: Drug Manufacturers - Specialty & Generic
Employés à temps plein: 14 100
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Ms. Kristin C. Peck | CEO & Director | 3,54M | 5,2M | 1971 |
Mr. Wetteny N. Joseph | Executive VP & CFO | 1,6M | S.O. | 1972 |
Ms. Wafaa Mamilli | EVP, Chief Digital & Tech. Officer, Group President for China, Brazil and Preci. Animal Health | 1,36M | S.O. | 1967 |
Dr. Robert J. Polzer Ph.D. | Executive VP and President of Research & Development | 1,18M | 54,13k | 1969 |
Mr. Steven Frank | Vice President of Investor Relations | S.O. | S.O. | S.O. |
Ms. Roxanne Lagano | Executive VP, General Counsel & Corporate Secretary | S.O. | S.O. | 1965 |
Mr. William Price | VP & Chief Communications Officer | S.O. | S.O. | S.O. |
Ms. Jeannette Ferran Astorga | Executive VP of Corporate Affairs & Communications and Chief Sustainability Officer | S.O. | S.O. | 1975 |
Mr. Nick Ashton | Executive VP and President of Global Manufacturing & Supply | S.O. | S.O. | 1973 |
Mr. Jamie Brannan | Executive VP and Group President International Operations of Aquaculture & Global Diagnostics | S.O. | S.O. | 1973 |
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
L’ISS Governance QualityScore de Zoetis Inc. en date du 28 août 2024 est 3. Les scores principaux sont Audit : 5; Société : 2; Droits des actionnaires : 7; Compensation : 2.